Literature DB >> 25869572

Diabetes: SDF-1 dysregulation mediates diabetic stem cell mobilopathy.

David Holmes.   

Abstract

Entities:  

Year:  2015        PMID： 25869572     DOI： 10.1038/nrendo.2015.63

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  2 in total

1.  Bone Marrow Macrophages Contribute to Diabetic Stem Cell Mobilopathy by Producing Oncostatin M.

Authors:  Mattia Albiero; Nicol Poncina; Stefano Ciciliot; Roberta Cappellari; Lisa Menegazzo; Francesca Ferraro; Chiara Bolego; Andrea Cignarella; Angelo Avogaro; Gian Paolo Fadini
Journal:  Diabetes       Date:  2015-03-24       Impact factor: 9.461

2.  Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor.

Authors:  Gian Paolo Fadini; Mark Fiala; Roberta Cappellari; Marianna Danna; Soo Park; Nicol Poncina; Lisa Menegazzo; Mattia Albiero; John DiPersio; Keith Stockerl-Goldstein; Angelo Avogaro
Journal:  Diabetes       Date:  2015-03-24       Impact factor: 9.461
  2 in total
  3 in total

1.  Transcriptional profiling reveals intrinsic mRNA alterations in multipotent mesenchymal stromal cells isolated from bone marrow of newly-diagnosed type 1 diabetes patients.

Authors:  Kalil A de Lima; Gislane L V de Oliveira; Juliana N U Yaochite; Daniel G Pinheiro; Júlia T C de Azevedo; Wilson Araujo Silva; Dimas T Covas; Carlos E B Couri; Belinda P Simões; Julio C Voltarelli; Maria C Oliveira; Kelen C R Malmegrim
Journal:  Stem Cell Res Ther       Date:  2016-07-12       Impact factor: 6.832

2.  Perivascular Cells and NADPH Oxidase Inhibition Partially Restore Hyperglycemia-Induced Alterations in Hematopoietic Stem Cell and Myeloid-Derived Suppressor Cell Populations in the Bone Marrow.

Authors:  Ji-Young Kim; Ji Yoon Lee; Kwon-Soo Ha; Eun-Taek Han; Won Sun Park; Chang-Ki Min; Seok-Ho Hong
Journal:  Int J Stem Cells       Date:  2018-03-30       Impact factor: 2.500

3.  Stem cell mobilization with plerixafor and healing of diabetic ischemic wounds: A phase IIa, randomized, double-blind, placebo-controlled trial.

Authors:  Benedetta Maria Bonora; Roberta Cappellari; Marta Mazzucato; Mauro Rigato; Marco Grasso; Mirko Menegolo; Andrea Bruttocao; Angelo Avogaro; Gian Paolo Fadini
Journal:  Stem Cells Transl Med       Date:  2020-06-02       Impact factor: 6.940
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.